SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-015231
Filing Date
2022-08-08
Accepted
2022-08-08 07:01:03
Documents
77
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q gbt-20220630.htm   iXBRL 10-Q 3540596
2 EX-10.1 gbt-ex10_1.htm EX-10.1 185726
3 EX-31.1 gbt-ex31_1.htm EX-31.1 16790
4 EX-31.2 gbt-ex31_2.htm EX-31.2 16880
5 EX-32.1 gbt-ex32_1.htm EX-32.1 14347
  Complete submission text file 0000950170-22-015231.txt   12091333

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gbt-20220630_def.xml EX-101.DEF 251749
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gbt-20220630_lab.xml EX-101.LAB 506359
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gbt-20220630.xsd EX-101.SCH 57964
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gbt-20220630_pre.xml EX-101.PRE 413130
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gbt-20220630_cal.xml EX-101.CAL 55921
71 EXTRACTED XBRL INSTANCE DOCUMENT gbt-20220630_htm.xml XML 2443830
Mailing Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37539 | Film No.: 221142495
SIC: 2834 Pharmaceutical Preparations